Stock Image

Central Nervous System Leukemia: Prevention and Treatment (Developments in Oncology)

Springer

0 ratings by Goodreads
ISBN 10: 9400967101 / ISBN 13: 9789400967106
Published by Springer, 2013
Condition: Good Soft cover
From Books Express (Portsmouth, NH, U.S.A.)

AbeBooks Seller Since 14 August 2015

Quantity Available: 1

Buy Used
Price: 262.46 Convert Currency
Shipping: Free Within U.S.A. Destination, rates & speeds
Add to basket

About this Item

Ships with Tracking Number! INTERNATIONAL WORLDWIDE Shipping available. May not contain Access Codes or Supplements. May be ex-library. Shipping & Handling by region. Buy with confidence, excellent customer service! Softcover reprint of the original 1st ed. 1983. Bookseller Inventory # 9400967101

Ask Seller a Question

Bibliographic Details

Title: Central Nervous System Leukemia: Prevention ...

Publisher: Springer

Publication Date: 2013

Binding: Paperback

Book Condition:Good

About this title

Synopsis:

In the past 10 to IS years there has been dramatic improvement in the survival of children with acute lymphoblastic leukemia. At the present time, over 50% of children with this disease will be alive and free of their disease at least 5 years from the time of their initial diagnosis. Although a number of factors have contributed to this improvement, perhaps none has been as important as the institution of central nervous system preventive therapy (eNS prophylaxis). However, despite the efficacy of eNS prophylaxis, the prevention and treatment of central nervous system leukemia continues to pose a formidable clinical challenge to the pediatric oncologist. Although successful in most cases, eNS preventive therapy remains ineffective for a small but significant subset of patients at high risk for developing eNS disease. Moreover, it has become increasingly evident that some methods of eNS preventive therapy are associated with long-term, adverse eNS sequelae. Thus, considerable controversy exists regarding the optimal method of eNS prophylaxis. Treatment of the patient who develops overt meningeal leukemia has not been as successful and continues to pose a major clinical challenge. Despite the ability of intrathecal chemotherapy and/or radiation therapy to induce eNS remission, most patients suffer subsequent relapse and ultimate survival is usually signifi- cantly compromised. It is evident that newer approaches to treatment for this patient group must be identified before major improvement for this patient group is likely to occur.

"About this title" may belong to another edition of this title.

Store Description

Visit Seller's Storefront

Terms of Sale:

Buy with confidence. Excellent customer service. 30 day return policy with a full refund if you are not completely satisfied with the book or its condition. Books Express LLC.

Shipping Terms:

Ships usually within one business day. Default shipping is by USPS Media Mail and frequently USPS Priority Mail or UPS Ground is used. Books should arrive within 5-45 business days for expedited shipping, and 7-60 business days for standard shipping. Standard shipping can on occasion take up to 60 days for delivery.

List this Seller's Books

Payment Methods
accepted by seller

Visa Mastercard American Express

Check Money Order PayPal Invoice Bank Draft Bank/Wire Transfer Direct Debit (Personally Authorized Payment)